Diabetes Care 30:1466-1472, 2007 DOI: 10.2337/dc06-2233 © 2007 by the American Diabetes Association
The Underuse of Screening Services Among Elderly Women With DiabetesFrom the Division of Health Policy and Management, School of Public Health, University of Minnesota, Minneapolis, Minnesota Address correspondence and reprint requests to A. Marshall McBean, MD, MSc, Division of Health Policy and Management, University of Minnesota School of Public Health, MMC 97, 420 Delaware St., SE, Minneapolis, MN 55455. E-mail: mcbea002{at}umn.edu OBJECTIVETo determine whether the use of nondiabetes-related preventive services (mammography, colorectal cancer screening, and bone density testing) among elderly diabetic women is different from the use among nondiabetic women.
RESEARCH DESIGN AND METHODSUsing a representative sample of the U.S. elderly female population and the linked Surveillance, Epidemiology, and End Results (SEER)-Medicare files, we identified women with or without diabetes who were RESULTSWomen with diabetes were less likely to have a mammogram (odds ratio [OR] 0.83 [95% CI 0.780.88]), colorectal cancer screening (0.79 [0.700.88]), and bone density testing (0.63 [0.580.69]). Women with diabetes seen by endocrinologists had significantly higher rates of bone density testing than women seen by primary care physicians. Women seen by obstetrician/gynecologists had the highest rates of use of all three services. CONCLUSIONSElderly women with diabetes are less likely to receive cancer and osteoporosis screening than women without diabetes. Physicians treating these patients need to assure that they receive all recommended preventive services appropriate for their age. Additional national guidelines, practice-based improvements, and patient education targeting those at greatest risk of not receiving these services may be needed to achieve parity.
Abbreviations: ADA, American Diabetes Association CDC, Centers for Disease Control and Prevention CMS, Centers for Medicare and Medicaid Services HCPCS, Healthcare Common Procedure Coding System SEER, Surveillance, Epidemiology, and End Results
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||